GlassScriptPhysician profile
Christopher David Catapano
NPI 1669732996
$6,878.55
in general payments reported to CMS, 2019-2025
25 companies · $527 in 2025
The $527 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,850 · 2020: $1,346 · 2021: $568 · 2022: $774 · 2023: $192 · 2024: $621 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $2,335.48 | 2019-2025 | |
| Stryker Corporation | $1,500.62 | 2019-2025 | Mako, N/A |
| Medical Device Business Services, INC. | $707.31 | 2019 | |
| Xtant Medical INC | $332.15 | 2024 | |
| Si-Bone, INC. | $316.01 | 2020-2024 | |
| Forte Bio-Pharma LLC | $306.99 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $234.13 | 2021-2023 | Relistor |
| Depuy Synthes Sales INC. | $206.65 | 2019 | |
| Nuvasive, INC. | $158.41 | 2019 | |
| Royal Biologics, INC. | $142.01 | 2019 | |
| Highridge Medical LLC | $125.68 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Smith+Nephew, INC. | $89.64 | 2020-2025 | Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $77.57 | 2019 | |
| Radius Health, INC. | $68.34 | 2022-2023 | Tymlos |
| Ibsa Pharma INC. | $55.11 | 2023-2024 | Tirosint, Licart, Flector |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $43.33 | 2025 | Roxybond |
| Merck Sharp & Dohme LLC | $33.35 | 2022 | |
| Arteriocyte Medical Systems, INC. | $29.55 | 2022 | |
| Cerapedics INC. | $27.17 | 2021 | |
| Orthofix Medical, INC. | $19.30 | 2023 | Spinal-Stim, Physio-Stim |
| Biohaven Pharmaceutical Holding Company LTD. | $18.04 | 2022 | |
| Abbott Laboratories | $14.09 | 2023 | Proclaim |
| Redhill Biopharma INC. | $13.18 | 2022 | |
| Avanos Medical | $13.00 | 2023 | Trivisc Sodium Hyaluronate |
| Expanding Innovations, INC. | $11.44 | 2025 | X-Pac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Catapano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.